The 12-month program will support Mediwhale in developing go-to-market plans and investment opportunities as the company looks to achieve FDA approval and expand into the U.S. market.
The company uses deep-learning algorithms to predict disease risk through retinal scans.
Currently, Mediwhale’s scans focus on cardiovascular, aging, kidney and eye health. The eye program shows a minimum 96 percent accuracy, according to a March 21 Mediwhale news release shared with Becker’s.
The MedTech Accelerator is the third active accelerator program Mediwhale has joined in the U.S.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
